It is currently Thu Sep 18, 2014 12:46 am
Opexa to Present at the Rodman & Renshaw 12th Annual Healthcare Conference on September 14, 2010
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, will deliver a corporate presentation at the Rodman & Renshaw 12th Annual Healthcare Conference. The conference will be held September 12-15, 2010 at the New York Palace ...
Total posts 219999 • Total topics 22745 • Total members 14351